Viremia and HIV-1 Drug Resistance Mutations Among Patients Receiving Second-Line Highly Active Antiretroviral Therapy in Chennai, Southern India | Zendy

Shanmugam Saravanan | Zendy; Vidya Madhavan | Zendy; Pachamuthu Balakrishnan | Zendy; Rami Kantor | Zendy; Sunil S. Solomon | Zendy; David Katzenstein | Zendy; N. Kumarasamy | Zendy; T. Yeptomi | Zendy; Sathasivam Sivamalar | Zendy; S. Rifkin | Zendy; Kenneth H. Mayer | Zendy; S. Solomon | Zendy

Open Access

Viremia and HIV-1 Drug Resistance Mutations Among Patients Receiving Second-Line Highly Active Antiretroviral Therapy in Chennai, Southern India

Author(s) -

Shanmugam Saravanan,

Vidya Madhavan,

Pachamuthu Balakrishnan,

Rami Kantor,

Sunil S. Solomon,

David Katzenstein,

N. Kumarasamy,

T. Yeptomi,

Sathasivam Sivamalar,

S. Rifkin,

Kenneth H. Mayer,

S. Solomon

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir967

Subject(s) - medicine , viremia , antiretroviral therapy , drug resistance , human immunodeficiency virus (hiv) , virology , second line , viral load , first line , genetics , biology

A cross-sectional study among individuals receiving second-line antiretroviral treatment was conducted to report on the level of detectable viremia and the types of drug resistance mutations among those with detectable human immunodeficiency virus (HIV) type 1 plasma viral loads (PVLs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research